ATE302008T1 - Behandlung von entzündlichen erkrankungen - Google Patents

Behandlung von entzündlichen erkrankungen

Info

Publication number
ATE302008T1
ATE302008T1 AT01963202T AT01963202T ATE302008T1 AT E302008 T1 ATE302008 T1 AT E302008T1 AT 01963202 T AT01963202 T AT 01963202T AT 01963202 T AT01963202 T AT 01963202T AT E302008 T1 ATE302008 T1 AT E302008T1
Authority
AT
Austria
Prior art keywords
treatment
inflammatory diseases
mefloquine
administration
treating
Prior art date
Application number
AT01963202T
Other languages
English (en)
Inventor
Benjamin Mark Skead
Robin Mark Bannister
Alan Rothaul
Original Assignee
Arakis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arakis Ltd filed Critical Arakis Ltd
Application granted granted Critical
Publication of ATE302008T1 publication Critical patent/ATE302008T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/49—Cinchonan derivatives, e.g. quinine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01963202T 2000-09-05 2001-08-31 Behandlung von entzündlichen erkrankungen ATE302008T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0021776.0A GB0021776D0 (en) 2000-09-05 2000-09-05 The treatment of inflammatory disorders
PCT/GB2001/003924 WO2002019994A2 (en) 2000-09-05 2001-08-31 The treatment of inflammatory disorders

Publications (1)

Publication Number Publication Date
ATE302008T1 true ATE302008T1 (de) 2005-09-15

Family

ID=9898880

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01963202T ATE302008T1 (de) 2000-09-05 2001-08-31 Behandlung von entzündlichen erkrankungen

Country Status (21)

Country Link
US (2) US7034028B2 (de)
EP (1) EP1315496B1 (de)
JP (1) JP2004508323A (de)
CN (1) CN1309388C (de)
AT (1) ATE302008T1 (de)
AU (2) AU8423401A (de)
BR (1) BR0113646A (de)
CA (1) CA2419601A1 (de)
DE (1) DE60112768T2 (de)
DK (1) DK1315496T3 (de)
ES (1) ES2245372T3 (de)
GB (1) GB0021776D0 (de)
HU (1) HUP0300934A2 (de)
IL (1) IL154419A0 (de)
MX (1) MXPA03001920A (de)
NO (1) NO323227B1 (de)
NZ (1) NZ524099A (de)
PL (1) PL364030A1 (de)
PT (1) PT1315496E (de)
WO (1) WO2002019994A2 (de)
ZA (1) ZA200301139B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0021776D0 (en) * 2000-09-05 2000-10-18 Arakis Ltd The treatment of inflammatory disorders
GB0406014D0 (en) * 2004-03-17 2004-04-21 Arakis Ltd Pharmaceutical composition and use
WO2006108666A1 (en) * 2005-04-13 2006-10-19 Proteosys Ag Mefloquine, nelfinavir and saquinavir as novel agents for neurodegenerative and (neuro-) inflammatory diseases
WO2008075366A2 (en) * 2006-12-20 2008-06-26 Medwell Laboratories Ltd. Novel conjugates of polyunsaturated fatty acids with amines and therapeutic uses thereof
JP2013530244A (ja) * 2010-07-07 2013-07-25 ポリメディックス・インコーポレーテッド 免疫調節の方法
CN113578299B (zh) * 2020-04-30 2023-11-10 中国石油化工股份有限公司 一种硅铝锆复合氧化物、催化裂化催化剂及其制备方法和应用
CN114452289B (zh) * 2020-12-31 2023-06-09 兰州大学 喹啉类衍生物在制备预防和/或治疗胃肠道疾病药物中的应用
CN114796216A (zh) * 2022-01-04 2022-07-29 南京医科大学 甲氟喹在防治全身代谢性炎症疾病中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03505579A (ja) * 1988-06-30 1991-12-05 デービス，マイクル，エイチ ヒト免疫不全ウイルス（ｈｉｖ）のインビボにおける活性の阻害方法
SK280617B6 (sk) * 1992-01-16 2000-05-16 Hoechst Aktiengesellschaft Arylcykloalkylové deriváty, spôsob ich prípravy, f
CA2185019C (en) * 1994-03-09 2000-08-08 Pfizer Limited Isoxazoline compounds as inhibitors of tnf release
DE69808440T2 (de) 1997-03-07 2003-07-10 Vernalis Research Ltd., Winnersh Verwendung von (+)mefloquine zur behandlung von malaria
WO1999026627A1 (en) * 1997-11-26 1999-06-03 Cerebrus Limited (-)-mefloquine to block purinergic receptors and to treat movement or neurodegenerative disorders
WO2000066107A2 (en) 1999-04-30 2000-11-09 Apt Pharmaceuticals, L.L.C. Antimalarian agents for the treatment of asthma
GB0021776D0 (en) * 2000-09-05 2000-10-18 Arakis Ltd The treatment of inflammatory disorders

Also Published As

Publication number Publication date
US20060074106A1 (en) 2006-04-06
HUP0300934A2 (hu) 2003-11-28
CA2419601A1 (en) 2002-03-14
US20040029916A1 (en) 2004-02-12
AU2001284234B2 (en) 2004-11-04
CN1309388C (zh) 2007-04-11
PL364030A1 (en) 2004-12-13
DE60112768T2 (de) 2006-02-02
EP1315496A2 (de) 2003-06-04
AU8423401A (en) 2002-03-22
ZA200301139B (en) 2004-03-29
PT1315496E (pt) 2005-11-30
NO323227B1 (no) 2007-02-05
HK1054324A1 (en) 2003-11-28
JP2004508323A (ja) 2004-03-18
GB0021776D0 (en) 2000-10-18
NZ524099A (en) 2004-04-30
US7034028B2 (en) 2006-04-25
BR0113646A (pt) 2004-01-06
WO2002019994A3 (en) 2002-05-16
NO20030985D0 (no) 2003-03-03
MXPA03001920A (es) 2004-02-12
DK1315496T3 (da) 2005-11-14
EP1315496B1 (de) 2005-08-17
CN1452488A (zh) 2003-10-29
ES2245372T3 (es) 2006-01-01
WO2002019994A2 (en) 2002-03-14
DE60112768D1 (de) 2005-09-22
NO20030985L (no) 2003-03-03
IL154419A0 (en) 2003-09-17

Similar Documents

Publication Publication Date Title
IL130931A0 (en) Small molecules useful in the treatment of inflammatory disease
DE60023043D1 (de) (S,S)-Reboxetin zur Behandlung von Inkontinenz
ATE472325T1 (de) Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen
ATE340171T1 (de) Piperazinderivate zur behandlung bakterieller infektionen
ATE350044T1 (de) Thrombopoietinmimetika
NO20041882L (no) Fremgangsmater for behandling av okulare neovaskulaere sykdommer.
MY155218A (en) Small molecules useful in the treatment of inflammatory disease
DE60218493D1 (de) Substituierte 7-aza-ä2.2.1übicycloheptane für die behandlung von krankheiten
BRPI0307673A2 (pt) métodos de tratar doença vascular.
DE60025632D1 (de) Thrombopoietin-mimetika
DE60032795D1 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
ES2192839T3 (es) Timosina beta 4 oxidada.
DE60139466D1 (de) Behandlung von diabetes
IS2259B (is) Aðferð til meðferðar á netjuhersli með notkun mótlyfs við integríninu alfa-4 undireiningunni
EA200401341A1 (ru) Применение остеопротегерина для лечения и/или профилактики фиброзного заболевания
EA200200742A1 (ru) 1,2-диарилбензимидазолы для лечения заболеваний, связанных с активацией микроглии
DE60112768D1 (de) Behandlung von entzündlichen erkrankungen
TR200200278T2 (tr) Kalsilitik bileşimler
PT1237562E (pt) Processo de preparacao de extractos de micania contendo micanolida e di-hidromicanolida e utilizacao no tratamento das doencas proliferativas
BR0115882A (pt) Emprego de compostos de 1-fenil-3-dimetilaminopropano no tratamento da incontinência urinária
DE69819922D1 (de) 2-Amino-6-methyl-7-acetyl-tetralin und pharmazeutische Zusammensetzungen zur Vorbeugung und therapeutischen Behandlung von entzündlichen und/oder Autoimmunkrankheiten
DK1244438T3 (da) Anvendelse af beta-adrenoceptorantagonister til fremstilling af et medikament til behandling af sygdomme i den ydre nethinde
NO20005548D0 (no) Mykobakterieinhibitorer
ATE343387T1 (de) S-methyl-dihydro-ziprasidon zur behandlung von augenerkrankungen.
ATE545421T1 (de) Pharmazeutisches präparat zur behandlung von parasitären tropenkrankheiten enthaltend diminazen-di-aceturat

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1315496

Country of ref document: EP

REN Ceased due to non-payment of the annual fee